You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IW-1701

Showing 1 - 25 of 76
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Achalasia Trial in United States (Olinciguat, Matching Placebo)

Terminated
Has Results
  • Achalasia
  • Bristol, Connecticut
  • +4 more
Apr 8, 2021

Sickle Cell Disease Trial in Lebanon, United Kingdom, United States (IW-1701, Placebo)

Completed
  • Sickle Cell Disease
  • IW-1701
  • Placebo
  • Orange, California
  • +36 more
Jul 18, 2021

Healthy Trial in Austin (Olinciguat, Itraconazole)

Completed
  • Healthy
  • Austin, Texas
    PPD
Jul 11, 2019

Healthy Trial in San Antonio (IW-1701, Matching Placebo)

Completed
  • Healthy
  • IW-1701
  • Matching Placebo
  • San Antonio, Texas
    Ironwood Investigational Site
Apr 1, 2019

Healthy Trial in San Antonio (IW-1701, Placebo)

Completed
  • Healthy
  • IW-1701
  • Placebo
  • San Antonio, Texas
    ICON Early Phase Unit
Apr 1, 2019

Healthy Volunteers Trial in Madison ([14C]-olinciguat)

Completed
  • Healthy Volunteers
  • Madison, Wisconsin
    Covance Clinical Research Unit Inc.
Apr 1, 2019

Healthy Volunteers Trial in Austin (IW-3300, Placebo)

Completed
  • Healthy Volunteers
  • Austin, Texas
    PPD
Sep 15, 2022

Interstitial Cystitis, Bladder Pain Syndrome Trial in Jeffersonville (IW-3300 rectal foam, Placebo)

Recruiting
  • Interstitial Cystitis
  • Bladder Pain Syndrome
  • IW-3300 rectal foam
  • Placebo
  • Jeffersonville, Indiana
    First Urology PSC
Feb 28, 2023

Locally Advanced Rectal Cancer Trial in Shanghai (SHR-1701;Capecitabine;Oxaliplatin)

Recruiting
  • Locally Advanced Rectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Zhongshan Hospital
Jul 26, 2022

Relapsed or Advanced NSCLC Trial (Almonertinib combined with SHR-1701, Almonertinib)

Not yet recruiting
  • Relapsed or Advanced Non-small Cell Lung Cancer
  • (no location specified)
Aug 16, 2022

Retinal Detachment Trial in Melbourne, Bangkok, Khon Kaen (ABV-1701, SF6 Gas)

Not yet recruiting
  • Retinal Detachment
  • ABV-1701
  • SF6 Gas
  • Syd, New South Wales, Australia
  • +3 more
Dec 7, 2022

Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • East Melbourne, Victoria, Australia
  • +7 more
Jan 20, 2023

MELAS Trial in United States (IW-6463 Tablets)

Completed
  • MELAS
  • IW-6463 Tablets
  • Washington, District of Columbia
  • +4 more
Jun 13, 2022

Healthy Volunteers Trial in Austin (IW-3300, Placebo)

Recruiting
  • Healthy Volunteers
  • Austin, Texas
    PPD
Jan 25, 2022

Solid Tumor Trial in China (SHR-1701)

Active, not recruiting
  • Solid Tumor
  • Hefei, Anhui, China
  • +15 more
Nov 6, 2022

Blood Circulation Disorder, Deep Vein Thrombosis Trial (Blood circulation device)

Not yet recruiting
  • Blood Circulation Disorder
  • Deep Vein Thrombosis
  • Blood circulation device
  • (no location specified)
Aug 19, 2022

Cervical Kyphosis, Cervical Lordosis, Kyphosis Trial (CGM MB-1701 device treatment, CGM MB-1701 Sham device treatment)

Not yet recruiting
  • Cervical Kyphosis
  • +2 more
  • CGM MB-1701 device treatment
  • CGM MB-1701 Sham device treatment
  • (no location specified)
Aug 2, 2022

Bacteremia Due to Staphylococcus Aureus, Left Sided Infective Endocarditis (Disorder), Right Sided Infective Endocarditis

Withdrawn
  • Bacteremia Due to Staphylococcus Aureus
  • +3 more
  • Tonabacase (LSVT-1701)
  • Butte, Montana
    Lsvt-1701-2001
Jun 27, 2022

Cervical Cancer Trial in Guangzhou (SHR-1701 + paclitaxel + cisplatin/carboplatin + BP102, SHR-1701 + paclitaxel +

Recruiting
  • Cervical Cancer
  • SHR-1701 + paclitaxel + cisplatin/carboplatin + BP102
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Mar 13, 2022

Pancreatic Cancer Trial in Beijing, Shanghai (SHR-1701)

Unknown status
  • Pancreatic Cancer
  • Beijing, China
  • +1 more
Sep 26, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (SHR-1701, Gemcitabine, Cisplatin)

Active, not recruiting
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    Cancer Hospital of Guangzhou Sun Yat-sen University
Dec 19, 2021

Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer Trial in

Enrolling by invitation
  • Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer
  • SHR-1701 injection
  • Placebo
  • Bengbu, Anhui, China
  • +19 more
Feb 8, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Beijing (SHR-1701)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Beijing, China
    Tumor Hospital of the Chinese Academy of Medical Sciences
Oct 28, 2021

Melanoma Trial in Shanghai (SHR-1701, Temozolomide)

Not yet recruiting
  • Melanoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 1, 2021

NSCLC, Stage III Trial (SHR-1701)

Not yet recruiting
  • NSCLC, Stage III
  • (no location specified)
Dec 14, 2021